Parkinsonism in viral, paraneoplastic, and autoimmune diseases

Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson’s disease

(2021) Achim Thomzig et al.   ACTA NEUROPATHOLOGICA

Challenges in the diagnosis of Parkinson's disease

(2021) Eduardo Tolosa et al.   LANCET NEUROLOGY

An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19

(2020) Serge Nataf   JOURNAL OF MEDICAL VIROLOGY

Central nervous system complications associated with immune checkpoint inhibitors

(2020) Alberto Vogrig et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry

(2020) Carlos Manuel Romero-Sánchez et al.   NEUROLOGY

α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease

(2020) Cecilia S. Lindestam Arlehamn et al.   Nature Communications

Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection

(2020) Antonio Méndez-Guerrero et al.   NEUROLOGY

Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza

(2020) Alexander E. Merkler et al.   JAMA Neurology

A case of probable Parkinson's disease after SARS-CoV-2 infection

(2020) Mikhal E Cohen et al.   LANCET NEUROLOGY

Coronavirus Disease 2019 and Parkinsonism: A Non‐post‐encephalitic Case

(2020) Ingrid Faber et al.   MOVEMENT DISORDERS

Subacute axial parkinsonism associated with anti-Ri antibodies

(2020) Chiara Di Schino et al.   NEUROLOGICAL SCIENCES

ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection

(2020) Lingli Zhou et al.   Ocular Surface

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

(2019) Martin Reck et al.   JOURNAL OF CLINICAL ONCOLOGY

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

(2019) Tony S K Mok et al.   LANCET

Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment

(2019) Martina Chirra et al.   European Journal of Internal Medicine

Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection

(2019) Wey-Yil Lin et al.   JAMA Neurology

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies

(2019) Divyanshu Dubey et al.   NEUROLOGY

Autoimmune and paraneoplastic movement disorders: An update

(2018) José Fidel Baizabal-Carvallo et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease

(2018) Emily M. Rocha et al.   NEUROBIOLOGY OF DISEASE

Infection-mediated autoimmune movement disorders

(2018) Alberto Cucca et al.   PARKINSONISM & RELATED DISORDERS

The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders

(2018) Valentina Damato et al.   MOVEMENT DISORDERS

Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease

(2017) E. Caggiu et al.   JOURNAL OF NEUROIMMUNOLOGY

Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity—syndrome of parkinsonism and ataxia

(2017) Sudheeran Kannoth et al.   NEUROLOGICAL SCIENCES

Clinical manifestations of the anti-IgLON5 disease

(2017) Carles Gaig et al.   NEUROLOGY

Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan

(2017) Shigeaki Suzuki et al.   NEUROLOGY

Parkinson's disease: Autoimmunity and neuroinflammation

(2016) Armando De Virgilio et al.   AUTOIMMUNITY REVIEWS

Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?

(2016) Elisa Caggiu et al.   JOURNAL OF NEUROIMMUNOLOGY

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

(2016) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease

(2016) Xiao-Yan Qin et al.   JAMA Neurology

Postencephalitic parkinsonism and selective involvement of substantia nigra in childhood

(2015) Ibtihel Rebai et al.   BRAIN & DEVELOPMENT

Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)

(2015) Y. M. Arabi et al.   INFECTION

Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4

(2015) Kun Li et al.   JOURNAL OF INFECTIOUS DISEASES

Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis

(2015) Monica M. Kurtis et al.   PARKINSONISM & RELATED DISORDERS

The association between infectious burden and Parkinson's disease: A case-control study

(2015) Xian-Le Bu et al.   PARKINSONISM & RELATED DISORDERS

Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies

(2015) Helena Ariño et al.   JAMA Neurology

Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies

(2014) Shekeeb S. Mohammad et al.   MOVEMENT DISORDERS

DPPX potassium channel antibody: Frequency, clinical accompaniments, and outcomes in 20 patients

(2014) W. O. Tobin et al.   NEUROLOGY

Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders

(2012) Russell C. Dale et al.   BRAIN

APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies

(2012) Debby Tsuang et al.   JAMA Neurology

Narcolepsy, REM Sleep Behavior Disorder, and Supranuclear Gaze Palsy Associated With Ma1 and Ma2 Antibodies and Tonsillar Carcinoma

(2011) Chris Adams et al.   ARCHIVES OF NEUROLOGY

Postencephalitic parkinsonism and basal ganglia necrosis due to Epstein-Barr virus infection

(2011) A. J. Espay et al.   NEUROLOGY

Coronaviruses Hijack the LC3-I-Positive EDEMosomes, ER-Derived Vesicles Exporting Short-Lived ERAD Regulators, for Replication

(2010) Fulvio Reggiori et al.   Cell Host & Microbe

Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy

(2010) M. Bokemeyer et al.   GUT

Adaptive immunity

(2010) Francisco A. Bonilla et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study

(2008) Daniel M. Forton et al.   JOURNAL OF HEPATOLOGY

Parkinson's disease: clinical features and diagnosis

(2008) J Jankovic   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2

(2008) J. Netland et al.   JOURNAL OF VIROLOGY

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

(2008) Josep Dalmau et al.   LANCET NEUROLOGY

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

(2008) Lars Bertram et al.   NATURE REVIEWS NEUROSCIENCE